Expertise in
3
conditions

Dr. Michael R. Sperling

Gastroenterology
113 Gainsborough Sq Ste 202, 
Chesapeake, VA 
Expertise in
3
conditions
113 Gainsborough Sq Ste 202, 
Chesapeake, VA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Sperling is a Gastroenterologist in Chesapeake, Virginia. Dr. Sperling is highly rated in 3 conditions, according to our data. His top areas of expertise are Hiatal Hernia, Congenital Diaphragmatic Hernia, Swallowing Difficulty, Deep Brain Stimulation, and Endoscopy.

His clinical research consists of co-authoring 419 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in VA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

113 Gainsborough Sq Ste 202, Chesapeake, VA 23320

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
Enrollment Status: Terminated
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
Stereotactic Laser Ablation for Temporal Lobe Epilepsy
Stereotactic Laser Ablation for Temporal Lobe Epilepsy
Enrollment Status: Completed
Publish Date: January 17, 2025
Intervention Type: Device
Study Phase: Not Applicable
Memory Retrieval and Encoding Investigated by Neural Stimulation
Memory Retrieval and Encoding Investigated by Neural Stimulation
Enrollment Status: Active_not_recruiting
Publish Date: November 05, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drug: YKP3089
Study Phase: Phase 3
A Phase 2a, Safety, Tolerability, Pharmacokinetics, and Quantitative EEG Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures
A Phase 2a, Safety, Tolerability, Pharmacokinetics, and Quantitative EEG Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures
Enrollment Status: Completed
Publish Date: September 08, 2022
Intervention Type: Drug
Study Phase: Phase 2
A 12-Month Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)
A 12-Month Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)
Enrollment Status: Completed
Publish Date: January 31, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions
An Open-Label, Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects Under Seizure and Normal Conditions
Enrollment Status: Completed
Publish Date: October 05, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials
Similar Doctors
Expertise in
29
conditions
Dr. David A. Johnson
Gastroenterology
Expertise in
29
conditions
Dr. David A. Johnson
Gastroenterology
885 Kempsville Rd, Suite 114, 
Norfolk, VA 
 (7.1 miles away)
757-466-0165
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Johnson is a Gastroenterologist in Norfolk, Virginia. Dr. Johnson is highly rated in 29 conditions, according to our data. His top areas of expertise are Heartburn, Gastroesophageal Reflux Disease (GERD), Hemorrhoids, Colonoscopy, and Endoscopy. Dr. Johnson is currently accepting new patients.

Expertise in
59
conditions
Dr. Douglas Howerton
Gastroenterology
Expertise in
59
conditions
Dr. Douglas Howerton
Gastroenterology

Capital Digestive Care LLC

113 Gainsborough Sq, Suite 101, 
Chesapeake, VA 
 (1.7 miles away)
757-436-3285
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Howerton is a Gastroenterologist in Chesapeake, Virginia. Dr. Howerton is highly rated in 59 conditions, according to our data. His top areas of expertise are Acute Pancreatitis, Childhood Pancreatitis, Choledocholithiasis, Endoscopy, and Pancreatectomy.

Expertise in
35
conditions
Dr. Suhas L. Deshmukh
Gastroenterology
Expertise in
35
conditions
Dr. Suhas L. Deshmukh
Gastroenterology

Capital Digestive Care LLC

1925 Glenn Mitchell Dr, Suite 102, 
Virginia Beach, VA 
 (6.9 miles away)
757-464-1644
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Suhas Deshmukh is a Gastroenterologist in Virginia Beach, Virginia. Dr. Deshmukh is highly rated in 35 conditions, according to our data. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Diverticular Disease, Diarrhea, Gastrectomy, and Colonoscopy. Dr. Deshmukh is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sperling's expertise for a condition
ConditionClose
      View All 41 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile